Stamford, CT -- (SBWIRE) -- 01/30/2014 -- Jet Life Penny Stocks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Vringo, Inc.(NASDAQ:VRNG),RF Micro Devices, Inc.(NASDAQ:RFMD), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), , J.C. Penney Company, Inc.(NYSE:JCP)
Vringo, Inc.(NASDAQ:VRNG) managed to keep its gain at 20.65% on above-normal volume of 46.02M shares. The stock settled at $4.79 after floating in a range of $4.49 to $5.45. Its latest price has reached market capitalization of $402.96 million. Its 52-week range has been $2.61 to $5.45. Vringo, Inc. (Vringo) is a development-stage company. The Company is engaged in developing software for mobile phones. It provides a platform, which allows users to create, download and share mobile entertainment content in the form of video ringtones for mobile phones. Vringo’s product consists of four components, such as
For How Long VRNG will fight for Profitability ? Read This Trend Analysis report
RF Micro Devices, Inc.(NASDAQ:RFMD) traded up on a volume of 37.56 million, higher than its standard daily volume. Shares have gained 941% to $5.35. Over the last twelve months, the stock has gained 8.36% and faced a worst price of $4.30. RF Micro Devices, Inc. is engaged in the design and manufacture of radio frequency (RF) solutions.
For How Long RFMD’s Gloss will Attract Investors? Find out via this report
Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA) settled -5.41% lower at $7.60 on below -normal volume of 21.08M shares during the last trading day. The stock has its 12-month high at $23 and 52-week low price was $2.15. It traded in a range of $7.55 to $7.95 during the last trading day. ARIAD Pharmaceuticals, Inc. (ARIAD) is a global oncology company focused on the discovery, development and commercialization of medicines for the cancer patients. ARIAD’s first medicine, Iclusig, is approved in the United States for the treatment of adult patients with chronic, accelerated or blast phase chronic myeloid leukemia that is resistant or intolerant to prior tyrosine kinase inhibitor (TKI) therapy or Philadelphia chromosome-positive acute lymphoblastic leukemia that is resistant or intolerant to prior TKI therapy.
Will ARIA Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, J.C. Penney Company, Inc.(NYSE:JCP) was down on low volume, trading at a volume of 18.54M versus its average daily volume of 25.42 million shares. At $6.29, the stock has attained market capitalization of 1.92 billion. J. C. Penney Company, Inc. is a holding company whose principal operating subsidiary is J. C. Penney Corporation, Inc. (JCP).
Why Should Investors Buy JCP After the Recent Fall? Just Go Here and Find Out
Jet Life Penny Stocks is always searching the market every day for massive penny stock runs before they happen so you don't have to. Our Penny Stock Newsletter also offers free Highly-Professional Grade stock charts and video charts from one of the most experienced and well-respected chartists in the penny stock industry.
Jet Life Penny Stocks is not a registered securities advisor. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides information on highlighted stocks via press releases, newsletters and company website, but this should not be construed as a recommendation to buy or sell. Please visit the company website for a more complete list of risks and disclosures.
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)